[6-K] Lloyds Banking Group plc Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Lloyds Banking Group announced on 23 September 2025 that it purchased 8,024,077 ordinary shares as part of its existing share buyback programme. The shares were bought from Morgan Stanley & Co. International plc at prices between 81.56p and 82.60p, with a volume-weighted average price of 82.0920p. The purchases were effected under instructions given on 20 February 2025 and the Company intends to cancel these shares. A full breakdown of individual trades is available in the announcement schedule via the provided RNS link. The disclosure was filed on Form 6-K for regulatory reporting purposes.

Positive

• Repurchase executed: 8,024,077 ordinary shares were purchased under the announced buyback programme
• Transparent pricing: Highest price 82.6000p, lowest 81.5600p, VWAP 82.0920p disclosed
• Cancellation stated: The Company intends to cancel the repurchased shares
• Regulatory compliance: Full trade breakdown provided in the RNS schedule per Market Abuse Regulation

Negative

• None.

Insights

Financial Analyst

TL;DR: Lloyds repurchased 8.02 million shares at ~82.09p and will cancel them, reflecting active execution of its announced buyback.

The transaction confirms the company is executing its previously announced buyback instructions dated 20 February 2025. The announcement provides precise trade volumes and prices, including VWAP of 82.0920p, and states the shares will be cancelled, which reduces share count on a telescope basis. The disclosure follows market abuse regulation requirements by providing a schedule of individual trades via RNS. No earnings, liquidity, or financing details are included in this filing.

Corporate Governance Expert

TL;DR: The company complied with disclosure rules, executed buybacks through an appointed broker, and intends to cancel the shares.

The report shows procedural compliance with Article 5(1)(b) of the Market Abuse Regulation by supplying a trade schedule. The buyback was executed through Morgan Stanley & Co. International plc under prior instructions, and cancellation is explicitly stated. The filing contains contact details for investor relations and media but does not provide aggregate programme limits or remaining authority, so governance context is limited to execution and disclosure compliance only.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16a

of the Securities Exchange Act of 1934

23 September 2025

LLOYDS BANKING GROUP plc

(Translation of registrant's name into English)

5th Floor

25 Gresham Street

London

EC2V 7HN

United Kingdom

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports

under cover Form 20-F or Form 40-F.

Form 20-F..X..     Form 40-F 

Index to Exhibits

Item

 No. 1 Regulatory News Service Announcement, 23 September 2025

           re: Transaction in Own Shares

23 September 2025

TRANSACTIONS IN OWN SECURITIES

Lloyds Banking Group plc (the "Company") announces today that it has purchased the following number of its ordinary shares, from Morgan Stanley & Co. International plc (the "Broker").

Ordinary Shares

Date of purchases: 23 September 2025

Number of ordinary shares purchased: 8,024,077

Highest price paid per share (pence): 82.6000

Lowest price paid per share (pence): 81.5600

Volume weighted average price paid per share (pence): 82.0920

Such purchases form part of the Company's existing share buyback programme and were effected pursuant to the instructions issued to the Broker by the Company on 20 February 2025, as announced on 21 February 2025.

The Company intends to cancel these shares.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as such legislation forms part of assimilated law as defined in the EU (Withdrawal) Act 2018), a full breakdown of the individual trades made by the Broker on behalf of the Company as part of the buyback programme is set out in the Schedule to this announcement available through the link below:

http://www.rns-pdf.londonstockexchange.com/rns/5172A_1-2025-9-23.pdf

- END -

For further information:

Investor Relations

Douglas Radcliffe                                                                                                                             +44 (0)20 7356 1571

Group Investor Relations Director

douglas.radcliffe@lloydsbanking.com

Corporate Affairs

Matt Smith                                                                                                                                         +44 (0)20 7356 3522

Head of Media Relations

matt.smith@lloydsbanking.com

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

LLOYDS BANKING GROUP plc

 (Registrant)

By: Douglas Radcliffe

Name: Douglas Radcliffe

Title: Group Investor Relations Director

Date: 23 September 2025

FAQ

What did Lloyds Banking Group (LYG) report on 23 September 2025?

The company reported it purchased 8,024,077 ordinary shares on 23 September 2025 as part of its existing buyback programme.

At what prices did LYG buy back shares on 23 September 2025?

The highest price paid was 82.6000p, the lowest was 81.5600p, and the volume-weighted average price was 82.0920p.

Who executed the share purchases for LYG?

The purchases were made from Morgan Stanley & Co. International plc acting as the Broker.

Will the repurchased shares be cancelled?

Yes. The filing explicitly states the Company intends to cancel the repurchased shares.

Under what authority were the buybacks effected?

The purchases were effected pursuant to instructions issued to the Broker on 20 February 2025, as announced on 21 February 2025.

Where can I find a full breakdown of individual trades?

A full breakdown is available in the Schedule to the announcement via the RNS link: http://www.rns-pdf.londonstockexchange.com/rns/5172A_1-2025-9-23.pdf